跳至主要内容
临床试验/NCT01259076
NCT01259076终止不适用

Effect of Weight Loss on Breast Density Using Both Digital Mammography and Breast MRI

Northwestern University1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
43
试验地点
1
主要终点
Change in BMI and breast density

研究概览

简要总结

Diagnostic procedures, such as digital mammography and MRI, may help measure how weight loss affects breast density in women who are at increased risk for breast cancer.

详细描述

OBJECTIVES: I. To determine if weight loss in patients undergoing Roux en Y gastric bypass procedures has any effect on breast density as measured by mammography and breast MRI. OUTLINE: GROUP I: Participants undergo mammography and MRI at baseline and 1 year. Participants also undergo gastric bypass surgery. GROUP II: Participants undergo mammography and MRI at baseline and 1 year. After completion of study treatment, patients are followed up at 1 year.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women eligible for gastric bypass surgery
  • Pre-menopausal women
  • All women will have signed an informed consent form prior to participating in study procedures

排除标准

  • Women with a history of breast cancer
  • Women currently taking exogenous hormone replacement therapy
  • Women currently taking a SERM
  • Women currently taking an aromatase inhibitor
  • Pregnant or lactating women
  • Women who have been pregnant or lactating in the past 2 years
  • Women who have metallic or other surgical implants
  • All subjects will have a determination of their estimated glomerular filtration rate (eGFR) within 24 hours of undergoing any study where gadolinium based contrast agents will be administered
  • Subjects should not have a known history of recent onset acute renal dysfunction
  • Subjects with a history of stable chronic renal dysfunction may participate in studies using GBCA based on their eGFR, as outlined below
  • Subjects should not have severe liver dysfunction, particularly when associated with kidney disease
  • Subjects should receive GBCAs in the perioperative period (i.e. within 4 weeks) after renal or liver transplantation

结局指标

主要结局

Change in BMI and breast density

时间窗: At baseline and year 1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effect of Weight Loss on Breast Density Using... | 临床试验